- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Growth at Reasonable Price
Chinese Pharmaceuticals & Biotech Growth at Reasonable Price
Results
4
0 new
4 companies
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥12.2b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥54.40
7D
2.4%
1Y
-4.2%
Xiamen Amoytop Biotech
Market Cap: CN¥29.7b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥73.03
7D
-1.1%
1Y
26.6%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥17.8b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥11.02
7D
5.5%
1Y
-20.2%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥37.9b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥84.31
7D
-0.8%
1Y
41.5%